Women with bipolar disorder face difficult reproductive decisions. Both clinical and epidemiological studies have found that they have a high risk of recurrence after childbirth.Reference Munk-Olsen, Laursen, Mendelson, Pedersen, Mors and Mortensen1–Reference Bergink, Bouvy, Vervoort, Koorengevel, Steegers and Kushner4 At the same time, pharmacological treatment may bear teratogenic and possible long-term effects on the offspring and does not guarantee against a recurrence.Reference Bergink, Bouvy, Vervoort, Koorengevel, Steegers and Kushner4, Reference Viguera, Whitfield, Baldessarini, Newport, Stowe and Reminick5 Women find it very difficult to get information about the risks involvedReference Dolman, Jones and Howard6 and in a survey conducted in the USA, 45% of 70 women with bipolar disorder had been advised by a clinician to avoid pregnancy.Reference Viguera, Cohen, Bouffard, Whitfield and Baldessarini7 Although the high risk of any postpartum episode for women with bipolar disorder is well established, there is less data to establish the specific risk for individual women. In particular, there is paucity of evidence on the impact of previous perinatal history to guide women with bipolar disorder contemplating further pregnancies.Reference Wesseloo, Kamperman, Munk-Olsen, Pop, Kushner and Bergink8
Our overarching aim was therefore to provide data from which a more individualised assessment of risk can be made to help women and their clinicians. We sought to quantify the risk of a recurrence associated with a second pregnancy and, in particular, the impact of an episode of affective psychosis or non-psychotic depression associated with her first pregnancy.
Method
Figure 1 describes sample selection and the analytic plan.
Fig. 1 Participant selection and analytic plan.
Participant recruitment and selection
Women were recruited via systematic (25.7%) and non-systematic (74.3%) methods as part of the Bipolar Disorder Research Network project (www.bdrn.org). Women recruited systematically had been identified through the screening of records of community mental health teams and invited to participate. Non-systematic recruitment included advertisements in general practitioner surgeries and the media, the engagement of patient support organisations and referrals from treating physicians. Women with schizoaffective disorder were significantly more likely than women with other DSM-IV bipolar subtypes9 to be systematically recruited (χ2 = 21.0063, d.f. = 3, P = 0.0001). Apart from diagnosis, no differences emerged in demographic and clinical variables between systematically and not systematically recruited women (Supplementary Table 1 available at https://doi.org/10.1192/bjp.2018.92).
Inclusion criteria for the current study were: (a) a lifetime diagnosis of DSM-IV bipolar disorder (type I, type II or not otherwise specified) or schizoaffective disorder, bipolar type; (b) multiparous women with a first and second pregnancy followed by live births; (c) onset of bipolar disorder before or concomitant with the first delivery. Women who were biologically related to another participant were excluded, in order to include only independent observations. This study received all necessary multiregion and local research ethics approvals by the West Midlands Multi-Centre Research Ethics Committee and participants provided written informed consent.
Assessment
Women were interviewed using a semi-structured diagnostic interview, the Schedules for Clinical Assessment in Neuropsychiatry.Reference Wing, Babor, Brugha, Burke, Cooper and Giel10 A life chart was completed and detailed information about family history of psychiatric disorders was collected. Women were also asked to complete a number of questionnaires and permission to review case notes was granted.
Based on the information gathered from the interviews, case-notes reviews and questionnaires, a best-estimate lifetime diagnosis was made according to DSM-IV and key clinical variables were rated. Interrater reliability was formally assessed using a randomly selected sample of 20 participants. The mean kappa statistic was 0.85 for DSM-IV diagnosis and ranged between 0.81 and 0.99 for other categorical variables; mean intraclass correlation coefficients were between 0.91 and 0.97 for continuous variables.
Obstetric history and information on psychiatric episodes occurring in pregnancy and within 1-year postpartum were also obtained from the interview and case notes. Despite the fact that current classification systems limit the postpartum period to 4–6 weeks after delivery, in the current analyses we examined episodes with onset during pregnancy and within 6 months of delivery, to reflect the clinical, everyday definition of the perinatal period.Reference Jones and Cantwell11 Affective psychosis was defined as an episode of DSM-IV mania, psychotic depression or mixed episode and depression defined as an episode of DSM-IV non-psychotic depression. We decided not to include perinatal hypomania in the analyses, because of the difficulties in assessing the clinical relevance of hypomanic symptoms in the postpartum period and the validity and reliability of a retrospective account. Indeed, mild postpartum hypomania may be adaptive in some women and in a prospective longitudinal study 11% of 207 women without a clinical history of bipolar disorder reported significant hypomanic symptoms (Highs Scale scores >7) 1-week postpartum.Reference Heron, Haque, Oyebode, Craddock and Jones12
Analytic plan
The conditional probability of a psychiatric outcome in the second perinatal period given the outcome of the first perinatal period was calculated using contingency tables. Simultaneous confidence intervals for the conditional probabilities were calculated using the method proposed by Sison & GlazReference Sison and Glaz13 and α = 0.95 with the function MultinomialCI in R.Reference May and Johnson14 We explored the extent of agreement between perinatal psychiatric outcomes using Cohen's kappa statistics for agreement and its confidence intervals.
As we were interested in personalising the prediction of the psychiatric outcome of the second perinatal period, we also explored the importance of a number of other clinical predictors, beside previous perinatal history. Predictors were chosen from the available data on the basis of the current literature and included: family history of bipolar disorder or perinatal mood disorders, history of childhood sexual abuse and emotional or physical abuse, lifetime comorbidity with panic attack disorder or generalised anxiety disorder, lifetime history of alcohol or substance use disorders, lifetime history of psychosis, number of episodes per year of illness, lifetime history of rapid cycling, prevalent polarity of lifetime mood episodes, DSM-IV diagnosis and whether the onset of bipolar disorder coincided with the first delivery and time interval between pregnancies. Missing data were imputed with the mice package in R. Outcome variables were (a) perinatal affective psychosis in women with bipolar I disorder or schizoaffective disorder, bipolar type and (b) perinatal non-psychotic depression in the whole sample.
We used two different approaches to variable selection: backwards stepwise logistic regression and reinforcement learning trees.Reference Zhu, Zeng and Kosorok15 We finally assessed the agreement between times of onset of perinatal episodes separately in (a) women with a history of non-psychotic depression during both the first and second perinatal period and in (b) those with episodes of affective psychosis in relation to both pregnancies. Only women for whom we had complete information on the week of onset of the episodes were included in the analyses. As times of onset were not normally distributed, we used Spearman rank correlations.
The function mosaic in the vcd package was used to create mosaic plots (cran.r-project.org/web/packages/vcd/index.html) and ggplot in ggplot2 (http://docs.ggplot2.org/current/) to plot the variation in the time of onset between a first and second perinatal episode within woman.
Results
Information on first and second pregnancy resulting in live births was available for 887 multiparous women with bipolar disorder. The demographic and clinical characteristics of the participants are shown in Table 1. Because our recruitment focused on more severe episodes of bipolar disorder, women affected by bipolar I disorder were overrepresented compared with rates of the bipolar subtypes in the general population (estimated lifetime prevalence of bipolar I and II disorder in the general population 0.6 and 0.4%, respectively).Reference Merikangas, Jin, He, Kessler, Lee and Sampson16
Table 1 Sample characteristics
The first lifetime episode of bipolar disorder occurred in relation to childbirth for 28% (222/797) of women. For women with a history of postpartum affective psychosis this proportion was even higher: 57% (108/190) of them did not have any psychiatric history prior to the postpartum episode.
The overall risk of a recurrence of a mood or psychotic episode in relation to a second pregnancy was 55% (288/519; 95% CI 50.2–60.1) for women with any previous perinatal history and 31% (114/368; 95% CI 26.4–35.9%) for those with no mood or psychotic episode in relation to the first pregnancy (χ2 = 51.227, d.f. = 1, P < 0.0001).
As women with bipolar II disorder and bipolar disorder not otherwise specified have not experienced manic episodes by definition, further results are presented separately from those of women with bipolar I disorder and schizoaffective disorder, bipolar type. Analyses limited to women recruited systematically led to similar results to the analyses conduced on the whole sample.
Bipolar I disorder and schizoaffective disorder, bipolar type
The rate of any recurrence in relation to second pregnancy was 55% (205/372, 95% CI 50.0–60.4%) for women with an episode in relation to first pregnancy and 34% (76/226, 95% CI 27.4–39.8%) for those with no history of perinatal episodes (depression or affective psychosis: χ2 = 25.184, d.f. = 1, P < 0.0001).
In the group of women with a history of perinatal affective psychosis 43% (79/185, 95% CI 35.7–50.7) had a recurrence of affective psychosis and a further 9% (17/185, 95% CI 2.2–17.2%) of non-psychotic depression in the second perinatal period.
In the group of women with a history of perinatal non-psychotic depression 50% (93/187, 95% CI 42.8–57.6) had a further episode of perinatal non-psychotic depression and 9% (16/187, 95% CI 1.6–16.5) experienced an episode of affective psychosis in relation to the second pregnancy (Table 2). Interestingly, even though women with no history of perinatal mood episodes were less likely to have an episode in relation to the second pregnancy, 34% still developed a perinatal mood episode in the second perinatal period, which included 10% (22, 95% CI 4.0–16.2%) with affective psychosis and 24% (54, 95% CI 18.1–30.4%) with depression (Table 2).
Table 2 Probability of having an episode in the second perinatal period, given the psychiatric outcome of the first pregnancy in women with bipolar I disorder or schizoaffective disorder, bipolar type
It is clear, therefore, from these findings that the clinical presentation (depression or affective psychosis) of the episode in the first perinatal period influenced the psychiatric outcome of the second pregnancy (agreement between episodes Cohen's kappa 0.29, 95% CI 0.23–0.35, P < 0.0001).
When the odds of having a recurrence in the second perinatal period were examined, women with an history of perinatal affective psychosis were six times more likely to develop a recurrence of affective psychosis (odds ratio (OR) = 6.0, 95% CI 3.43–10.90) compared with women without any episode in the first perinatal period. An episode of non-psychotic depression in relation to the first pregnancy significantly but less strongly increased the odds of a non-psychotic depressive recurrence (OR = 3.3, 95% CI 2.10–5.23) but these women were not at a significantly higher risk of an affective psychosis (OR = 1.4, 95% CI 0.64–2.97) in the second perinatal period, compared with women without perinatal psychiatric history.
Bipolar II disorder and bipolar disorder not otherwise specified
The rate of any recurrence in the second perinatal period was 56% (83/147, 95% CI 49.0–65.2%) for women with an episode of depression or affective psychosis in relation to a previous pregnancy and 27% (38/142, 95% CI 19.7–34.0%) for those with no history of perinatal episode (χ2 = 24.975, d.f. = 1, P = 0.0001, Table 3).
Table 3 Probability of having an episode in the second perinatal period, given the psychiatric outcome of the first pregnancy in women with bipolar II disorder and bipolar disorder not otherwise specified
The odds of a non-psychotic depressive episode in the second perinatal period were significantly higher in women with a history of non-psychotic depression during the first perinatal period than in those without a perinatal history (OR = 4.0, 95% CI 2.32–6.95).
Multivariate prediction modelling
Although we found a strong association between the psychiatric outcome of the first and second pregnancies, many other clinical variables are likely to be associated with perinatal recurrences. We therefore investigated how important perinatal history was among other possible clinical predictors using random forests. Separate analyses were conducted to examine variables that influence risk of (a) postpartum affective psychosis, (b) non-psychotic depression with onset in pregnancy, and (c) non-psychotic depression with onset within 6 months of childbirth. For postpartum affective psychosis, analysis was limited to women with bipolar I disorder or schizoaffective disorder but for non-psychotic depression the analysis involved the whole sample. The clinical variables evaluated were: family history of bipolar disorder or perinatal mood disorders, history of childhood sexual abuse and emotional or physical abuse, lifetime comorbidity with panic attack disorder or generalised anxiety disorder, lifetime history of alcohol or substance use disorders, lifetime history of psychosis, number of episodes per year of illness, lifetime history of rapid cycling, prevalent polarity of lifetime mood episodes, DSM-IV diagnosis and whether the onset of bipolar disorder coincided with the first delivery and interval between pregnancies. We obtained the same results with different random seeds.
The receiver operator characteristic areas for the logistic regression models were 0.78 for affective perinatal psychosis, 0.80 for depression in pregnancy and 0.71 for postpartum depression (Supplementary Fig. 1).
The psychiatric outcome of the first pregnancy was the most significant variable associated with the psychiatric outcome of the second pregnancy (logistic regression effect size: 5 for postpartum affective psychosis, 4.9 for depression in pregnancy and 6.5 for postpartum depression; all P<0.001). Information on other clinical variables only modestly improved our ability to predict the psychiatric outcome of the second pregnancy (Supplementary Fig. 2). Using logistic regression, we also found statistically significant positive associations between postpartum psychosis and number of episodes per year of illness (β = 0.4070; s.e. = 0.141; z-value = 2.893; P = 0.004; logistic regression effect size = 1.6 compared with 5.0 for history of postpartum psychosis) and postpartum depression and depression as the most prominent polarity of illness (β = 1.130; s.e. = 0.416; z-value = 2.717; P = 0.006; logistic regression effect size = 2.8 compared with 7.5 for history of postpartum psychosis).
Timing of onset
A further important clinical issue is whether the timing of the onset in relation to delivery for a previous perinatal episode is predictive of the timing of onset of a further episode. For example, if a woman has had a previous postpartum episode with a specific time of onset, can we use this knowledge to predict the period of highest risk of a perinatal recurrence. Although in clinical practice this may often be assumed, there is no research to our knowledge that has addressed this issue.
As previously observed,Reference Di Florio, Forty, Gordon-Smith, Heron, Jones and Craddock2 onset of affective psychosis was almost exclusively (90%, 253/282) within the first 6 weeks after childbirth, whereas the onset of non-psychotic depression was more spread out across the perinatal period, with only 59% (247/415) occurring in the first 6 weeks after childbirth. We tested the hypothesis that there was a correlation between times of onset of perinatal episodes separately in (a) women with a history of non-psychotic depression during both their first and second perinatal period, and (b) those with episodes of affective psychosis in relation to both pregnancies. Only women for whom we had complete information on the week of onset of the episodes were included in the analyses.
In women with two episodes of perinatal depression (n = 170), we found an association between the timing of onset of the first and the second episode (Spearman correlation 0.57, P < 0.001).
There was considerably less variation in the time of onset of episodes of affective psychosis, with 74% (n = 54) of women having both psychotic episodes within the first month after childbirth. We therefore did not calculate the Spearman correlation coefficient for affective psychosis.
Discussion
In this study we wanted to identify if there are easily obtainable clinical variables that can inform the discussion of risk associated with further pregnancies in women with bipolar disorder.
Predictors of perinatal recurrence
We examined a wide range of factors that clinicians can easily establish during the consultation with women with bipolar disorder who plan a second pregnancy, from family history to course of illness. Of great interest, a history of perinatal affective psychosis or depression was the most robust factor associated with a further perinatal recurrence. None of the other variables we were able to examine significantly improved our ability to predict the psychiatric outcome of the second pregnancy. We found that 55% of women who experienced an episode of affective psychosis or depression in pregnancy or following childbirth had a recurrence in a subsequent perinatal period, consistent with previous estimates obtained in a number of much smaller studies.Reference Wesseloo, Kamperman, Munk-Olsen, Pop, Kushner and Bergink8
Women with a history of postpartum psychosis have an almost one in two risk of a manic/psychotic recurrence after a subsequent delivery. Although it is established that a history of postpartum psychosis is a major risk factor for developing a second psychotic episode in the postpartum,Reference Blackmore, Rubinow, O'Connor, Liu, Tang and Craddock17 previous studies have not investigated the influence of a history of perinatal non-psychotic depression, despite its high prevalence in women with bipolar disorder.Reference Di Florio, Forty, Gordon-Smith, Heron, Jones and Craddock2 We found in fact that, contrary to our expectations, the risk of having any form of perinatal recurrence was slightly higher in women with a history of non-psychotic perinatal depression than in those with a history of postpartum affective psychosis. Our results therefore emphasise the need in women with bipolar disorder to take into account all previous perinatal episodes, including depression and not to focus exclusively on the most severe episodes of illness. Although women with postpartum psychosis are at the highest risk of developing a further severe postpartum episode, women with bipolar disorder with a history of perinatal depression have in fact the highest rates of any form of recurrence.
Parous women without history of perinatal illness may still develop a perinatal episode in subsequent pregnancies
There is a lack of information on risk in further pregnancies to women with bipolar disorder who had a first child without psychiatric complications. In clinical practice the risk is often treated as for a first pregnancy in a woman with bipolar disorder, even though the risk may be lower as they have had an opportunity to experience a perinatal episode but remained well. Although confirming the suspicion that these women were at lower risk, we found that the absence of mood episodes in or following the first pregnancy does not guarantee that women will not experience a perinatal episode of illness in relation to subsequent pregnancies. About a third of women will experience some form of perinatal episode in a second pregnancy even if they had no episode of illness following a first pregnancy.
Women who remained well through the first perinatal period did appear to be at lower risk of affective psychosis and interestingly the rates of a subsequent episode of perinatal affective psychosis were similar in women with a history of perinatal depression (9%) and in those without any perinatal history (8%). Although this estimate is much lower than the 44% recurrence rate in women with a history of postpartum psychosis after a first delivery, it is still higher than that observed in the literature in women without a psychiatric historyReference Munk-Olsen, Laursen, Pedersen, Mors and Mortensen18 or in those with a history of other mental disorders.Reference Munk-Olsen, Laursen, Mendelson, Pedersen, Mors and Mortensen1
Likely presentation and timing of a further episode follow the characteristics of the first perinatal episode
It is not known whether there are specific and separate puerperal triggers for postpartum psychosis and postnatal depression. A previous study on 45 women with bipolar disorder and at least two postpartum episodes reported a complete concordance between the polarities of perinatal episodes.Reference Maina, Rosso, Aguglia and Bogetto19 In our study we found that there was a moderate, but not complete, agreement between the clinical presentation of a first and a second perinatal episode (44% for affective psychosis, 48% for depression and 64% for non-occurrence in bipolar I disorder).
Because of the large sample size, we were also able to compare the timing of onset of perinatal depression in women with both a first and a second delivery affected. Again, we found a moderate agreement, with about one in two episodes of depression starting in the same perinatal week as the previous perinatal episode. Our results may therefore not only inform clinicians and patients on the most likely presentation of a bipolar episode in the perinatal period, but also on the likely time of onset.
Strengths and limitations
In our research we analysed information from a large data collection of women with bipolar disorder (the largest in the literature), with a detailed description of the perinatal episodes and lifetime history. Data were obtained from multiple sources and interrater variability was formally assessed.
Because of the retrospective design of the study, the lifetime research diagnosis allocated to each woman was that appropriate at the time of assessment not at each pregnancy. Moreover, we could not assess the importance of a number of potentially important variables, such as mood stability in pregnancy, complex longitudinal patterns of illness, medications that were prescribed during the perinatal period and the woman's adherence to treatment. Although there is evidence that lithium reduces the risk of relapse in pregnancy and after childbirth,Reference Bergink, Bouvy, Vervoort, Koorengevel, Steegers and Kushner4, Reference Viguera, Whitfield, Baldessarini, Newport, Stowe and Reminick5, Reference Austin20 data for other widely used medications are sparse.Reference Wisner, Hanusa, Peindl and Perel21, Reference Sharma, Smith and Mazmanian22 Previous studies found that rates of recurrence in women taking medication in the perinatal period were lower than in those without prophylaxis, but still high, ranging between 20 and 50%.Reference Bergink, Bouvy, Vervoort, Koorengevel, Steegers and Kushner4, Reference Viguera, Whitfield, Baldessarini, Newport, Stowe and Reminick5, Reference Wisner, Hanusa, Peindl and Perel21Reference Munk-Olsen, Laursen, Mendelson, Pedersen, Mors and Mortensen1, Reference Sharma, Smith and Mazmanian22 It is however, possible that women with a previous episode of postpartum psychosis are more likely to take prophylactic medication in a subsequent pregnancy and following childbirth than those who did not experience a perinatal episode. We had data on medication at the time of delivery for a subsample of 52 women with bipolar disorder recruited during pregnancy and followed up after childbirth. At the time of delivery, the majority of them was taking a mood stabiliser (28, n = 54%); over one-third were not taking any medication (n = 20, 38%). Because of the complexity of prescription regimes, adherence to treatment and pharmacokinetics changes in the perinatal period, it was not possible to draw conclusions on the effect of medications.
Despite these limitations, our models fit significantly better than the null models (see Supplementary Fig. 1) and represent progress compared with general information on risk given to women with bipolar disorder.
Implications
In this study, we have examined the rates of perinatal recurrence in women with bipolar disorder. We found a high risk of a recurrence with further pregnancies. Although the rates were significantly higher in women with previous perinatal psychiatric history, women without such episodes were still at risk of developing perinatal illness. The clinical presentation (affective psychosis v. non-psychotic depression and time of onset in relation to delivery) of the first perinatal episode predicted the presentation and onset of subsequent perinatal episodes. Although women with postpartum affective psychosis were at the highest risk of developing a further severe postpartum episode, those with a history of perinatal non-psychotic depression had the highest rates of any mood episode recurrence.
Our study will be of benefit in individualising the risk of perinatal episodes in parous women with bipolar disorder. The risk estimates are summarised in Tables 2 and 3 and a risk assessment flow chart is proposed in Fig. 2 that can be used for preconception and pregnancy counselling. This will help women and their clinicians make the very difficult decisions they face regarding pregnancy.
Fig. 2 Flow chart for risk assessment of perinatal episodes in women with bipolar disorder who have already had children.
Supplementary material
Supplementary material is available online at https://doi.org/10.1192/bjp.2018.92.
Funding
This work was supported by grants from the Wellcome Trust (078901) and the Stanley Medical Research Institute (6045240–5500000100). ADF is funded by a 7th Framework Programme European Commission Marie Curie International Outgoing Fellowship, grant number 623932.
Acknowledgements
The authors thank all the women who gave their time to participate in the study.
Open access
eLetters
No eLetters have been published for this article.